Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
作者信息
Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K
出版信息
Ann Rheum Dis. 2003 Oct;62(10):1019-20. doi: 10.1136/ard.62.10.1019.
Abstract
摘要
相似文献
1
Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.青霉胺对系统性硬化症患者肺纤维化的影响。
Ann Rheum Dis. 2003 Oct;62(10):1019-20. doi: 10.1136/ard.62.10.1019.
2
D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).青霉胺治疗系统性硬化症（硬皮病）患者的肺部受累情况。
Arthritis Rheum. 1987 Jul;30(7):832-4. doi: 10.1002/art.1780300716.
3
[Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
Wien Klin Wochenschr. 1976 Apr 30;88(9):292-5.
4
Cystic lung disease in systemic sclerosis: a case report with high resolution computed tomography findings.系统性硬化症中的肺囊性疾病：一例伴有高分辨率计算机断层扫描结果的病例报告
Rev Rhum Engl Ed. 1996 Mar;63(3):213-5.
5
D-penicillamine in systemic sclerosis? Yes!
Scand J Rheumatol. 2001;30(4):192-4. doi: 10.1080/030097401316909503.
6
Clinical trials for the treatment of systemic sclerosis/scleroderma.
Curr Rheumatol Rep. 1999 Oct;1(1):13-4. doi: 10.1007/s11926-999-0018-0.
7
[D-penicillamine: an outdated cure for systemic scleroderma?].[D-青霉胺：系统性硬化症的一种过时疗法？]
Rev Med Interne. 1999 Dec;20(12):1077-81. doi: 10.1016/s0248-8663(00)87520-7.
8
Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine.
Int J Dermatol. 1997 Jun;36(6):476-7. doi: 10.1111/j.1365-4362.1997.tb01138.x.
9
Combination therapies for systemic sclerosis.系统性硬化症的联合治疗
Springer Semin Immunopathol. 2001;23(1-2):109-29. doi: 10.1007/s002810100058.
10
D-penicillamine is not an effective treatment in systemic sclerosis.
Scand J Rheumatol. 2001;30(4):189-91. doi: 10.1080/030097401316909495.
引用本文的文献
1
Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.系统性硬皮病相关间质性肺病疾病严重程度、临床病程和结局的判断异质性：系统文献回顾。
RMD Open. 2023 Nov;9(4). doi: 10.1136/rmdopen-2023-003426.
2
Antifibrosis: to reverse the irreversible.抗纤维化：逆转不可逆转的。
Clin Rev Allergy Immunol. 2010 Apr;38(2-3):276-86. doi: 10.1007/s12016-009-8157-7.
3
Interstitial lung disease in systemic sclerosis.系统性硬化症中的间质性肺疾病
Lung. 2007 Jul-Aug;185(4):211-20. doi: 10.1007/s00408-007-9012-3.
4
Differing distributions of CXCR3- and CCR4-positive cells among types of interstitial pneumonia associated with collagen vascular diseases.胶原血管病相关间质性肺炎各类型中CXCR3阳性细胞和CCR4阳性细胞的分布差异。
Virchows Arch. 2007 Jan;450(1):51-8. doi: 10.1007/s00428-006-0330-2. Epub 2006 Nov 24.
5
Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy.环磷酰胺脉冲治疗6个月后系统性硬化症患者肺功能的改善
Clin Rheumatol. 2006 Nov;25(6):819-21. doi: 10.1007/s10067-005-0173-2. Epub 2006 Jan 27.
Zotero 插件